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Various dermal fibrotic conditions, such as progres-
sive systemic sclerosis, localized morphea and familial 
cutaneous collagenoma. are characterized by excessive 
deposition of collagen in the skin. In the present study, 
we examined the possibility that a circulating serum 
factor(s) is responsible for increased collagen production 
in these diseases. The effects of human serum on the 
synthesis of procollagen were examined by incubating 
normal human dermal fibroblasts with ["H]proline and 
varying concentrations of dialyzed heat-inactivated se-
rum. The synthesis of pro collagen was measured as for-
mation of nondialyzable ["H]hydroxyproline and colla-
genase-digestible 3H-polypeptides. In the absence of se-
rum little pro collagen was formed but the synthesis was 
markedly stimulated by the addition of normal serum in 
a concentration-dependent manner. The ratio of geneti-
cally distinct :lH-procoliagens of type I and type In, 
assayed by DEAE-cellulose chromatography and SDS-
polyacrylamide gel electrophoresis after limited pepsin 
proteolysis, was unaffected by the addition of serum. 
Thus, normal human serum contains a nondialyzable 
factor(s) which stimulates the synthesis of procollagens 
type I and type In equally. Sera from 5 patients with 
progressive systemic sclerosis, 3 with localized sclero-
derma; and 2 with familial cutaneous collagenoma were 
also tested. Sera from these patients failed to stimulate 
3H-procollagen production more than sera from healthy 
age-matched controls. Therefore. no increased quanti-
ties or qualitatively aberrant factors were shown. to be 
present in the sera of these patients. 
Factors in serum have been known to regulate cellular fun c-
t ions by affecting a variety of processes, such as movement, 
viabili ty, proliferation and protein synthesis [2,3]. Most of the 
studi es exploring these effects have ut ilized fetal calf serum in 
cell systems derived from animals of various species. However, 
few studies have been concerned with the effects of huma n 
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serum on human cells and , in parti cular , on the synthesis of 
various macromolecules. 
Collagen, the major fibrillar component of the connect ive 
t issues [4,5], comprises approx imately 80% of the dry weight of 
huma n dermis [4]. Aberrations in the metabolism of collagen 
have been suggested to play a n important role in the pathoge n-
esis of several clinical condit ions [4-7] and recently, serum 
fa ctors have been implicated in the development of some of 
these diseases [8-13). Thus, in the present study we have 
examined the effects of human serum on the production of type 
I and type III pro collagens, the major extracellular gene prod-
ucts of normal huma n skin fibroblasts in culture. The sera were 
obtained from normal human subj ects as well as (i'om patients 
with various forms of dermal fibroses, viz. progressive systemic 
sclerosis, localized scleroderma and famili al cutaneous collagen-
oma. The resul ts indicate that normal human se rum contains 
factor(s) which markedly increase the production of type I a nd 
III procollagens by the cells. However, no evidence of a factor 
which might fur ther stimulate procollagen synthesis was noted 
in the serum of patients with vari ous fibroti c diseases. 
MATERIALS AND METHODS 
Clinical 
Patien ts with a variety of derma l fibrot ic diseases, such as progressive 
systemic scleros is (PSS), localized scleroderma (morphea) a nd fa milia l 
cutaneous co Llagenoma (FCC), we re examined at the Division of Der-
mato logy, Washington University School of Med icine a nd Ba rnes H os-
pita l, S l. Louis, Missouri. B lood samples from such pat ienls a nd from 
normal , healthy, age a nd sex-matched subjects we re obta ined by venous 
puncture a nd a llowed to clot overnight a t 4°C. Sera were obtai ned by 
centrifugation a t 5,000 xg for t5 min , dia lyzed aga inst 0.15 M NaCI-Tris 
buffer, pH 7.6, con ta ining 0.03 M Hepes for 2 days wit h 3 cha nges of 
dialysis solu t ion. In some experiments, nondialyzed sera were used. 
S ubsequently, the sera were hea ted at 56°C for 30 min to inac tivate 
the complement and sterilized by millipore filtrati on be fore mixing with 
Dulbecco's modified E agle's medium prior to incuba tion in the ce ll 
cultures. 
Hum.an Shin Fibroblast Cultures 
Cell cultures were ini t iated from punch biopsies or from skin obtained 
from surgica l procedures a fter obta ining informed consent. Cells were 
mainta ined in Dulbecco 's modified Eagle's medium conta ining glu ta-
mine (KC Biologica ls) supplemented with 30 mM Hepes bu ffer, pH 7.6, 
200 uni ts/ml of penicillin , 200 /Lg/ ml of streptomycin a nd 20% feta l 
bovine serum. ConOuen t prima ry ce ll cul tures were t ryps inized, sub-
cultured in 75 cm~ fl asks (Fa lcon Plastics) in 5% CO~-95% a ir envi ron-
ment a t 37°C. The ce lls were grown to con flu ency, rinsed extensively 
with seru'm-free medium , a nd then replaced in fresh medium supple-
mented with 0, 10,20, 40, and ()O% serum obtained from norma l huma n 
subj ects or 20% serum from pa tien ts with va rious forms of derma l 
fibroses. Ascorbic ac id, 25 /Lg/ ml , a nd /1-a minopropionitrile, 20 I'g/ ml, 
were added to the medium. After a 4- hr pre incuba l ion period , the ce lls 
were labe led with ["H]pro line (30 ,lCi/ fl ask) or ["Hlglyc ine (30 /LCi; 
fl ask) for 20 h at 37°C [14 ,15l 
Assays for Collagen Biosynthesis 
Following the 20-h r la beling period. the med iulll was removed a nd 
cooled at 0-4 °C a fter adding pro tease inhibitors to give fina l concen· 
t rations of 20 mM disodiulll EDTA, 10 mM N-ethy lma leimide a nd 0.3 
mM phenylmethy lsulphonylfluoride. The ce ll laye rs were rinsed 3 times 
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wi t h serum-free medium at 4°C, scra ped with a rubber policeman in to 
5 ml of solu t ion conta ining 0.4 M NaCl-Tris buffer (pH 7.5) and the 
SaITl e protease inhibitors as above, and sonicated at 60 Hz for 30 sec. 
T o quantitate the synthesis of hydroxypro line, al iquots of medium and 
h orrlOgenized cell fractions were dialyzed against running tap water, 
h y drolyzed in 6 N HCl in sealed tubes at llO°C for 24 hI' and assayed 
fo r n ondialyzable ["H]hydroxypro line using a specific radiochemical 
m eth od [1 6]. Further independent quantitation of radioactively- labeled 
coUagen was performed using a bacterial collagenase assay [1 7]. Ali -
quots of medium and ceil homogenates were dia lyzed extensively 
against 0.15 M NaCl-Tris buffer (pH 7.5) conta ining ] mM disodium 
EDT A. Purified bacterial collagenase (Advanced Biofactors) (final 
con centration, 50/lg/ ml ) in 0.15 M NaCl-Tris buffer (pH 7.5) , 10 mM 
Cael" 25 mM N-ethylmaleimide and J mM phenylmethylsulphonyl-
fluoride was added. Samples were incubated for 6 hI' at 30°C. Digestion 
was h alted wi th one-tenth volume of 0.25 M disodium EDTA and the 
saITl ples were dialyzed against 0.15 M NaCl-Tris buffer (pH 7.5) con-
taining 25 mM disodium EDTA, 25 mM N-et.hy lmaleimide and 1 mM 
phenylmethylsulphonyHluoride at 4°C. The amoun t of collagenous 
proteins was measured by the release of radioactive pep tides by dialysis 
[17,18]. 
Chro m.atographic Pl'ocedul'e~ 
Synthesis of genetica lly distinct procollagens was examined by la-
beling the cells with ["H]pro line under similaJ' conditions as above. 
Following the addit ion of protease inhibitors to the medium "H-procol-
lage n was isolated by precipitation wi th ammonium sulfate, lJ4 mg per 
ml (20% saturation), for DEAE-cellulo e chromatography [15,19,20]' 
The precipitate was collected by centrifugation at 30,000 xg for 30 min 
a nd d issolved in 4 ml of star t ing buffer: 25 mM Tris-HC1. pH 7.5. 
con taining 2 M urea and] mM disodium EDTA. The sample was 
dialyzed against the same buffer for 90 min at 4°C with 2 changes of 
th e buffer. Collagenous prote ins were chromatographed on a 2.5 x 10.0 
cm column of microgranular (pre-swollen) DEAE-cellulose (DE 52; 
Whatman Biochemicals Ltd.). Type I and type III procollagens were 
e lu ted separately using a lineal' gradient of 150 ml of st.arting buffer (2 
M urea and 1 mM disodium EDTA in 25 mM Tris-HCI, pH 7.5) and 150 
ml of limi t buffer (0.22 M NaCI, 2 M urea and 1 mM disodium EDTA in 
25 rnM Tris-HCI, pH 7.5) , at 8°C. The flow rate wa 180 ml/h; 4- ml 
fractions were collected and 0.2 ml aliquots were counted in 3 ml ACS 
coun t ing solu t ion (Amersham) . The peaks of radioactive protein were 
pooled and aliquots were dialyzed against running tap water fpr deter-
mination of nondialyzable proline and hydJ'oxyproline, as clescribed 
previously [16,18]. 
Other A ssays 
For DNA and total cell protein assay aliquots of homogenized cell 
fractions were dialyzed against 0. 15 M NaCl, 1 mM Tris-HC1, pH 7.5. 
DNA was assayed by a diphenyla mine method [21] and ce ll protein by 
a method according to Lowry et al [22]. Interrupted SDS-polyacryl-
a mide gel electrophoresis of the medium "H-labeled proteins after 
limite d pepsin proteolysis was performed as described previously [15, 
23]. 
RESULTS 
Effects of Normal Human Sera 
In initial experiments, the effects of control ser a obtained 
from healthy human individuals were examined. Incubation of 
normal human skin fibroblasts in confluent cultw'es with ['lH]-
proline in the presence of vru'ying concentrations of huma n 
serunl indicated t hat the serum m arkedly incr eased t h e pro-
duction of nondialyzable [:JH]hydroxyproline (Fig 1). The larg-
est proportional increase was noted with 10 and 20% serum 
concentrations, Although the proportional stimulation was less 
at higher concentrations the maximum synth esis of 
[3H]hydroxyproline-containing macromolecules based on cell 
protein or DNA was obtained at a 60% serum concentration 
(Fig 1). 
Since the varying serum concentrations could be thought to 
affect the degree of hydroxylation of prolyl residu es, a n inde-
pendent assay for the synthesis of 3H-labeled collagenous pro-
teins was also employed. In this procedLll'e, t h e' release of 
dialyzable aH-peptides by digestion with purified bacterial col-
lagenase was taken as an index of collagen synthesis. The 
results again indicated that the addition of serum to th e incu -
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Ftc 1. Th e effects of varying concentrations of norma l human serum 
on the production of ["H]hydroxyproline-containing macromolecules 
by human skin fibroblast.s. The ce lls in conflu ent monolayer cultures 
were incubat.ed with ["Hlproline in the presence of varying serum 
concent rations, as indicated in the Mate rials and Met.hods. At the end 
of incubat.ion, the nondialyzable ["H]hydroxyproline was assayed in 
medium and cell fractions. Also, the amounts of cellular protein and 
DNA were determined, as described in t.he text. The values represent 
["H]hydJ'oxyproline in tota l (cells + medium) culture expressed per mg 
protein (a) or pel' mg DNA (b). The values are mean ± SE of 3 paJ'a llel 
f1asks. 
ba tion m edium mru'kedly enhanced t he production of collage-
nous polyp eptides, the high est enhancem e n t being obtained 
with 60% concentration (Fig 2). 
Since fetal cal f serum has been previously hown to stimulate 
collagen production by cultured fibroblasts [14], it was of in te r-
est to compal'e the re lative stimulatory capacit ie of huma n a nd 
bovine sera. As shown in T a ble I, both huma n and fetal calf 
serum in a 20% concen tration enha nced t he syn t hesis of non-
dialyzable CH]hydroxyproline to a n equal degree, th e elevation 
be ing about 20-fold. It should be noted that t h e total incorpo-
ration of CH]proline into nondia lyzable proteins was also e n-
ha nced by bot h huma n a nd fetal calf sera abou t 20-fold. T hus. 
it appears t hat, in addit ion to stimulation of collagen produc-
tion, th e synthesis of no nco llageno us proteins is incr eased as 
well (Table I). 
In further experimen ts, the secretion of CH]hydr oxypro line-
containing m acromolecul es was examined by separately assay -
ing the nondialyzable CH]hydroxyproline in t he medium a nd 
cell layer fractions . The r esul ts indicated th at at t h e end of a 20 
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FI G 2. The effects of vary ing concentrations of normal human serum 
on the formation of bacteria l collagenase-digestible "H-protein. The 
cells were incubated with ["H]glyc ine, as indicated in Fig 1. At t he end 
of t he incubation, t he "H-polypeptides rendered dialyzable by digestion 
with a purified bac teria l collagenase were assayed as indicated in 
Materia ls and Methods. The values were expressed as cpm pel' mg 
cellular prote in (a) or per mg DNA (b). The values are mean ± SE of 
3 para llel flasks. . 
TABLE I. Effects of normal human serum and fetal calf serum on 
total incO/pomtion of ( 'H]proline into protein and nondialyzable 
{J H] hydroxyproline 
Total "H-Incorporation ["H]H ydroxyproline 
Serum, % (dp m X (-fold (dpm X (-fold 
l Q-"/mg s t.imula- 10-"/lllg stilllula-
protei n)" t ion)" prole inr' tion)" 
Co ntrol,O% 10.4 ± 8.2 13.2 ± 6.6 
Fetal ca lf serum, 20% 212.9 ± 25.0. 20.5 211.4 ± 120.5 IG.O 
Human serum, 20% 264.4 ± 30.7 25.4 29 1.0 ± 100.8 22.0 
"The va lues are mean ± SO from 3 para ll el flasks. 
" The va lues indicate the degree of stimulation over the controls incubated 
wit.hout. se rum . 
hl' incubation most of the 3H -procollagen was found in the 
medium (Table II) . Serum in increasing concentrations, al-
though markedly stimulatory for the total [, 'H]hydl'oxyproline 
production, did not affect the relative distribution of 3H-pro-
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collagen between the medium and cell layer fractions (Table 
II). 
Since a previous study [24] has suggested that in some cell 
systems the relative syn thesis of genetically distinct procolla-
gens type I a nd type III is alte red by fetal calf serum, t he 
synthesis of these pro collagens was also studied in the presence 
of 0, 20 and 60% concentrations of human serum. The newly -
synthesized type I and type III :JH-procollagens which were 
secreted into t he medium were separated by DEAE-cellulose 
chromatography employing methodology which we have re-
cently optimized for assay of these genetically distinct procol-
lagens [15]. The results indicated that the chromatographic 
patterns of .1H-labeled medium proteins were similar in cul tures 
incubated in the presence' of 0, 20 or 60% concentrations of 
human serum (Fig 3). In order to quant itate the relative ratios 
of type I/IlI ~H-procollagens, th e radioactive "H-proteins in 
peaks corresponding to type I and type III procollagens were 
pooled (see Fig 3) and their contents of eH]hydroxyproline 
were assayed [15]. As shown in Table III, no consistent differ-
ences in the relative synthesis of type I and type III procoll agens 
were noted in 2 separate experiments. It should be noted that 
the relative proportion of type III procoUagen was somewhat 
variable in the 2 experiments, probably due to differences in 
th e fibroblast Jines used. Similar results were obtained when 
type I and type III collagen ratios were estimated by interrupted 
SDS-gel electrophoresis after limited pepsin proteolysis (results 
not shown). 
On t he basis of the above experiments, we concluded t hat 
normal human serum markedly stimulates eH]procollagen syn-
thesis by cultUl'ed skin fibroblasts, th e enhancement being 
directed equally towards synthesis of type I and type III pro-
collagens. Since the highest proportional stimulation of 3H_ 
procollagen production was noted wi th a 20% serum concentra-
tion, in subsequent studies employing sera from a variety of 
patients wi th dermal fibroses, the 20% concentration was se-
lected for routine use. 
Studies with Sera from Patients with Dermal Fibroses 
Since previous studies have suggested that circulating factors 
might stimulate the production of connective tissue macromol-
ecules by skin fibroblasts in a variety of diseases [9-13], we 
examined the effects of sera from patients wi th active progres-
sive systemic sclerosis, localized scleroderma, and familial cu-
taneous collagenoma [25- 27]. 
Progressive Systemic Sclerosis (PSS) 
Sera from a total of 5 patients with active PSS were exam-
ined. Normal fibroblasts were incubated with ["H]glycine, and 
the synthesis of "H-labeled collagenous proteins was measUl'ed 
by the release of dialyzable "H-peptides by bacterial collagenase 
digestion. The results indicated that no marked or consistent 
stimulat ion or inhibition of the procollagen synthesis was noted 
with PSS sera when compared to cultures incubated concomi-
tantly with control sera from normal human subj ects (Table 
IV). Similar results were obtained when the collagen production 
TABLE II . Synthesis and secretion oeH-pl'Ocollagen in the presence 
of varying concentrations of normal human serum. 
Serum Medium Cells 
concentration ["HjHydroxy- % ["H1H ydroxy- % (% ) proline" of total" proline" of total' 
0 33.9 ± 5.2 65.6 17.8 ± 2.6 34.4 
10 118.0 ± 14.3 74.0 41.4 ± 5.4 26.0 
20 192.1 ± 19.7 75.0 63.9 ± 7.4 25.0 
40 211.4 ± 21.8 64.0 118.8 ± 25.9 36.0 
60 250.3 ± 32.5 70.6 104.4 ± 18.0 29.4 
" The values are nondialyzable ["H]hydroxyproline as dpm x 10-'1 
mg DNA; mean ± SD of 3 parallel fl asks. 
/, The values are t he mean in each group as percent of total dpm 
hydroxyproline in cells plus medium. 
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F I G 3. Separation by DEAE-cellulose chromatography of type I and 
type III "H-procollagens synthesized by human skin fibroblasts in the 
presence of varying concentrations of normal human serum. T he cells 
were incubated with ["H]proline in the presence of 0, 20 or 60% dialyzed, 
complement-inactivated serum. The newly-synthesized type I and type 
III procoLlagens were separated by DEAE-cellulose chromatography, 
as indicated in Materials and Methods. The peaks representing type I 
a nd type III procollagens were pooled , as indicated by the horizon ta l 
bars, and assayed for nondialyzable ["H]hydroxyprol ine. 
TAULE III. R elative production of type land type III procollogens 
by hUl/wn skin fibroblasts in the presen ce of varying concentrations 
of normal humoll serum 
Serum Type I Type III 
concentration 
(%) (dpm x 10-")" (%)', (d pm x 10-")" ('iO b 
Experiment I 
0 13.3 73. 1 4.9 26.9 
20 64.6 80.0 16.2 20.0 
60 324.7 8 1.6 73. 1 18.4 
Experiment 2 
0 48.1 89.4 5.7 10.6 
20 271.7 85.3 47.0 14 .7 
" The values represent ["H]hydroxyproline in the peaks correspond-
ing to type 1 and type III procollagen isolated by DEAE:cellulose 
chro matography, as shown in Fig 3. 
I , The values represent the relative distribu tion of ["Hlhydl'ox-
y proline in type I and type III procollagens. 
was monitored by assaying the synthesis of nondialyzable 
eH]hydroxyproline. Although occasionally increased values 
were obtained in the presence of PSS serum (e.g., PSS serum 
1 in Table IV, such increases were variable in that t hey were 
less than 1.5-fold over the corresponding controls and were not 
consistently observed in subsequent experiments. Similru' ex-
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TABLE IV . Effects of sera from po.tients with pl'Ogressive systemic 
sclerosis (PSS), localized scleroderma (morphea) and familial 
cutaneous collagenom.a (FCC) on 3 H -procollagen production by 
cultured skin fib roblasts" 
"H-procollagen production" 
era 
Experiment I 
PSS 1 
PSS 2 
PSS 3 
Controls (n = 3) 
Experiment II 
Morphea 1 
Morphea 2 
Morphea 3 
Controls (n = 3) 
Experiment III 
FCC 1 
Control I 
FCC 2 
Control 2 
Collag,cnase-digestible 
. H-protein 
(cpm/ mg 
cell protein) 
(x 10-") 
1.3 ± 0.2 
0.9 ± 0.4 
0.8 ± 0.4 
1.0 ± 0.4 
1.5 ± 0.1 
1.4 ± 0.1 
1.0 ± 0.1 
1.1 ± 0.3 
(cpm/ mg 
DNA) 
(x 10- ';) 
3.8 ± 0.8 
3.4 ± 1.7 
2.4 ± 0.7 
2.9 ± 0.6 
1.6 ± 0.2 
2.2 ± 0.3 
1.4 ± 0.1 
1.5 ± 0.4 
['H)Hydroxyproline (dpm/ mg 
cell protein) 
(x 10- 6) 
7.1 ± 0.1 
5.0 ± 0.5 
5.3 ± 0.2 
4.4 ± 0.9 
4.0 ± 1.4 
4.6 ± 2.0 
4.4 ± 0.9 
2.5 ± 0.3 
2.4 ± 0.1 
3.3 ± 0.6 
2.9 ± 0.6 
" Confluent skin fibroblast cul tures from normal adul t individuals 
were incubated with ["H]proline in the presence of 20% concentration 
of sera from patients or from age-matched control subjects, as indicated 
in materials and methods. "H-procoLiagen production was measured by 
assaying the coLlagenase digestible "H-protein and non-clialyzable 
["H]hydroxyproline. The determinations represent the sum of radio-
activity in both medium and ce Ll fractions. 
/, The values are mean ± SE of 3 parallel flasks. 
periments were also performed with sera which were not di-
alyzed before mixing with the cultw'e medium. In accordance 
with t he resul ts obtained with dialyzed sera, no stimulat ion of 
["H) hydroxyproline synthesis was noted . It appears, therefore, 
t hat sera from the patients with PSS studied here do not have 
a c i.rculating serum factor, e it her dia lyzable or nondialyzable, 
which would s ignificantly stimulate procollagen production by 
cultw'ed skin fibroblas ts over that seen when the cells were 
incubated with normal control serum. 
Localized Scleroderma 
Experiments similar to those described above were also per-
form ed with sera from 3 pat ients wi th localized scleroderma. 
Sera from these patients also did not stimulate "H-procoUagen 
production in excess of that by the sera from age- and sex-
matched control subjects, whether the collagen synthesis was 
monitored by the formation of bacte rial collagenase-degradable 
"H-protein or ["H) hydroxyproline (Table IV). 
Familial Cutaneous Collagenoma (FCC) 
This inherited condition is characterized by the presence of 
connective tissue nevi of t he collagen type [27]. Incubation of 
nondialyzed sera from 2 patients with FCC failed to increase 
the formation of nondialyzable ["H]hydroxyproline by skin 
fibroblasts above that by the sera obtained from heal t hy con-
trols (Table IV). 
DISCUSSION 
In the present study we have demonstrated that normal adul t 
human serum m al'kedly stimulates th e production of procolla-
gen by normal human skin fibroblasts in cul ture. This enha nce-
ment was of the same order of magnitude as was noted with 
the corresponding concentration of fetal calf serum. It appears, 
therefore, that the stimulating factor(s) is present not only in 
developing animals, but also may be a feature of adult serum. 
It is important to emphasize that the incr eased synthesi of 
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pro collagen was monitored by 2 independen t means, i.e., by 
assay of the newly-synthesized [3H]hydroxyproli ne and by mea-
suring eH]glycine-labeled polypeptides degradable by purified 
bacterial collagenase. T h e concordance of these 2 measure-
ments indicates that the observed increases in collage n syn the-
sis cannot be explained on t he basis of differences in the degree 
of prolyl hydroxylation in the presence of varying serum con-
centrations. Instead, the effect appears to be on the level of 
synth esis of pro collagen polypeptides. Although the mechanism 
of the serum effect is unclear at the present, the factors present 
in serum might stimulate protein syn thesis on the transcrip-
tional or translational level. In that case, the stimulatory effect 
could be directed towards the synthesis of proteins in general 
a nd not be limited to procollagen polypeptides. In support of 
this suggestion is the observa tion that the total incorporation 
of [,JH]proline into nondialyzable proteins was stimulated by 
serum to the same extent as that into non-dialyzable ['lH]-
hydroxyproline (see Table I) . 
Another mechanism which could t heoretically expla in the 
differe nces in collagen production involves t he in tr acellular 
degradation of newly-syn th esized 3H-labeled polypeptides 
[28,29]. T his possibility seems unlikely, however , since in order 
to explain the differences observed between 0 and 60% serum 
concentrations, approximately 80 to 90% of the newly-synthe-
sized polypeptides should have become dialyzable in the ab-
sence of serum a nd well over half of th e same pept ides would 
have to be degraded int racellularly in 20% serum concentra tion. 
S ince the intracellular degradation of newly-synthesized colla-
gen polypeptides in confluent human skin monolayer cul tures 
in th e presence of 20% serum represents only a bout one-tenth 
of the total translated a -chains [14] and since in tracellular 
degradation has been shown to be independent of serum [28], 
it seems unlikely that this pathway could expla in the diffe rences 
noted in the presence of varying serum concentrations. Finally, 
the increased synthesis of 3H-labeled collagenous proteins was 
of the same order of magni tude whether expressed per D NA or 
per cell protein. T hus, collagen production is enhanced on a per 
cell basis and is independent of any effects of serum on cell 
proliferation . 
H uman skin fibroblasts in cul ture have been shown to syn-
thesize genetically distinct procollagens of type I and type III 
[14,15,20]. It has been reported that fetal calf serum modulates 
the synthesis of genetically distinct collagens by human gingival 
fibroblasts; serum enhanced type I collagen production several-
fold while type III collagen synthesis was increased only slightly 
[24]. As a result, the ratio of type IIIII collagens markedly 
decreased wit h increasing serum concentrations. In contrast, in 
the present study, no marked ch anges in type lIIII collagen 
ratio were noted in the presence of 0, 20 or 60% human seru m. 
Also, we have previously shown th at varying concentrations of 
fetal calf ser um, although stimulatory for procollage n synthesis 
in 0-30% concentrations, did not change this ratio [14]. These 
results, together with previous observations [14], suggest that 
the synth esis of type I and type III procollagens by human skin 
fibroblasts, bu t not necessarily by other cell types [24,30,31], is 
under relatively r igid control. 
A variety of diseases affecting skin have been suggested to 
involve a circulating factor(s) which might stimulate the pro-
duction of connective tissue macromolecules by skin fibroblasts 
[9-13]. For example, fibroblasts from the pretibial area have 
been shown to synthesize 2 to .3 times more hyaluronic acid 
when incubated in serum fro m patients wi th pretibial myxe-
dema than when incubated in normal human serum [10]. R e-
cently, preliminary reports have also suggested that collagen 
syn th esis by normal skin fibroblasts is enhanced by a factor 
present in the serum from patients wi t h PSS [12,13]. However , 
the enhancement of total collagen biosynthesis in these studies 
was only 1.5-fo ld [13]. In t he present study, no evidence of a 
serum factor capable of enhancing collagen production by con-
trol cells was noted. Although increased values up to 1.5-fold 
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over the controls were noted occasionally, these cha nges were 
not statistically significa nt. It should also be noted that, in 
accordance with a recent study [32], no evidence of cytotoxic 
effects of PSS sera in the skin fibroblast cultm es was observed. 
S ince previous studies have indicated that PSS fibroblasts in 
the presence of feta l calf serum synthesize excessive a mounts 
of procollagen in cul ture [33- 36], it appears that the excessive 
collagen deposit ion in PSS is a sequela of a cellular aberration 
rather t han the result of the presence of a circulating factor 
which enhances collagen production. T hese resul ts, however, 
do not exclude the possibili ty t hat the deposit ion of collagen in 
PSS t issue is modulated by factors, such as the presence of 
fibronectin in the lower der mis [37] or by the action of various 
immune cell products [38- 40]. 
In conclusion, we have demonstrated t hat normal huma n 
serum contains factor(s) which markedly stimulates pro collagen 
production by normal human fibroblasts in cul ture. The fac-
tor (s) is nondialyzable and it is heat-stable at 56°C for at least 
30 min. N o increased qua ntit ies or qu ali tatively aberrant factors 
were shown to be presen t in t he sera of patients wi t h PSS, 
localized scleroderma or FCC. 
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